VESNUA

Swiss trademark · 513635 · Word mark · In force

Register entry

Registration number
513635
Application number
52655/2003
Status
In force
Type
Word mark
Filed
Jul 25, 2003
Registered
Aug 21, 2003
Published
Sep 4, 2003
Protected until
Jul 25, 2033
Priority
30.01.2003 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von immunologischen Störungen, virale Störungen, HIV und AIDS.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  2. Apr 5, 2023

    Renewed

    Published in Swissreg on 05.04.2023

  3. Apr 18, 2016

    Address changed

    Owner
    Agouron Pharmaceuticals, Inc., 10777 Science Center Drive, San Diego, CA 92121, USA → Agouron Pharmaceuticals, LLC, 10646 Science Center Drive, San Diego, CA 92121, USA

    Published in Swissreg on 18.04.2016

  4. Apr 10, 2013

    Renewed

    Published in Swissreg on 10.04.2013

  5. Dec 10, 2007

    Agent’s address changed

    Representative
    E. Blum & Co., Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 239 of 10.12.2007

  6. Dec 27, 2006

    Agent entered

    Representative
    Wild Schnyder AG, Forchstrasse 30, Postfach 1077, 8032 Zürich → E. Blum & Co., Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 250 of 27.12.2006

  7. Sep 4, 2003

    Registered

    Published in the SOGC no. 169 of 04.09.2003

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.